Copyright © 1999 by the European Society of Cardiology.
Editorial
Sympathetic overactivity and exercise intolerance in heart failure: a cause-effect relationship
Clinica Medica, University of Milan, Ospedale S. Gerardo, Monza
Centro di Fisiologia Clinica e Ipertensione IRCCS, Ospedale Maggiore, Milano, Italy
References
- Leimbach WM, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913919
[Abstract/Free Full Text] - Grassi G, Seravalle G, Cattaneo BM. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:32063211
[Abstract/Free Full Text] - Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615621
[Abstract/Free Full Text] - Kaye D, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler M. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570578[Abstract]
- Middlekauff HR, Hamilton MA, Stevenson LW, Mark AL. Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation. 1994;90:17941798
[Abstract/Free Full Text] - Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity and congestive heart failure. Hypertension. 1998;31:6467
[Abstract/Free Full Text] - Grassi G, Cattaneo BM, Mancia G. Sympathetic nervous system. Poole Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS. Heart Failure. New York: Churchill Livingstone; 1297. p. 188214
- Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;22 (Suppl A):72A84A
- Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819823[Abstract]
- Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:12571263[Abstract]
- Notarius CF, Ando S, Rongen GA, Floras JS. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J. 1999;:
- Volterrani M, Clark AL, Ludman PF. Predictors of exercise capacity in chronic heart failure. Eur Heart J. 1994;15:801809
[Abstract/Free Full Text] - Drexler H. Reduced exercise tolerance in congestive heart failure and its relation to neurohumoral factors. Eur Heart J. 1991;12 (Suppl C):2128
- Cohn JN. Efficacy of vasodilators in the treatment of heart failure. J Am Coll Cardiol. 1993;22 (Suppl A):135A138A
This article has been cited by other articles:
![]() |
H. R. Middlekauff, J. Chiu, M. A. Hamilton, G. C. Fonarow, W. R. MacLellan, A. Hage, J. Moriguchi, and J. Patel Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1956 - H1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ciarka, J.-L. Vachiery, A. Houssiere, M. Gujic, E. Stoupel, S. Velez-Roa, R. Naeije, and P. van de Borne Atrial Septostomy Decreases Sympathetic Overactivity in Pulmonary Arterial Hypertension Chest, June 1, 2007; 131(6): 1831 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Middlekauff, J. Chiu, M. A. Hamilton, G. C. Fonarow, W. R. MacLellan, A. Hage, J. Moriguchi, and J. Patel Muscle mechanoreceptor sensitivity in heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1937 - H1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure Eur. Heart J., May 2, 2002; 23(10): 800 - 805. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


